{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-302288","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2022-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.239571+00:00","generated_at":"2026-06-21T06:17:05.557272+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Benitec Biopharma increases authorized common shares from 40M to 160M","bullets":["Stockholders approved amendment at Dec 7, 2022 annual meeting; effective Dec 9, 2022.","Authorized common shares increased from 40,000,000 to 160,000,000.","Certificate of Amendment filed with Delaware Secretary of State on Dec 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-302288","json":"https://secwatch.observer/filing/0001193125-22-302288.json","markdown":"https://secwatch.observer/filing/0001193125-22-302288.md","text":"https://secwatch.observer/filing/0001193125-22-302288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/0001193125-22-302288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/d429664d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:17:05.557272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ed94150912c5b696e483809b310dc490469afba","claim":"Benitec Biopharma Inc.: Increased authorized shares of common stock from 40,000,000 to 160,000,000 (effective 2022-12-09).","evidence_excerpt":"the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock of the Company from 40,000,000 to 160,000,000.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/0001193125-22-302288-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2022-12-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}